Horn advised Scopio Labs on the deal. Scopio Labs completed the collaboration agreement with Siemens Healthineers to Distribute Full-Field Digital Cell Morphology Technology. Scopio Labs provides digital...
Scopio Labs’ Collaboration Agreement with Siemens Healthineers
Depa Infrastructure Single Member’s Acquisition of Shares of Thessaloniki – Thessalia Gas Distribution
KG advised ENI Plenitude in the deal. ENI Plenitude executed the sale and transfer of the 49% of the shares of Thessaloniki – Thessalia Gas Distribution...
ART MEDICAL Ltd.’s Agreement with Teva Pharmaceuticals
Horn & Co. advised ART Medical Ltd. on the deal. Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units....
VBL Therapeutics’ Merger with Notable Labs
Horn & Co. represented VBL Therapeutics on the deal. VBL Therapeutics executed the merger with Notable Labs. The merger aims to create Nasdaq-listed, clinical-stage therapeutic platform company developing new...
Purple Biotech’s Acquisition of Immunorizon
Horn&Co. advised Immunorizon on the deal. Purple Biotech executed the acquisition of Immunorizon in consideration for up to $100 million. Purple Biotech Ltd. is a clinical-stage company...
Pangea’s Seed Investment Round
Horn & Co. advised Pangea on the deal. Pangea executed a seed investment round. Pangea Biomed is a multi-cancer response predictor improving the effectiveness of precision oncology....
INX Digital Company’s Joint Venture with SICPA
Horn & Co. advised The INX Digital Company on the deal. The INX Digital Company, Inc. executed a joint venture with SICPA SA in the field...
Kamari Pharma’s $8 Million Raising Fund
Horn & Co. advised Kamari Pharma on the deal. Kamari Pharma executed a joint venture agreement raising $8 million. Kamari Pharma is a biopharmaceutical company that is developing...
Diagnostic Robotics’ Series B Fundraising
Horn & Co. represented Diagnostic Robotics in the deal, Amit, Pollak, Matalon & Co. advised StageOne, Migdal Insurance, Clal Insurance and Bank Hapoalim on the transaction....
Qualigen Therapeutics’ Acquisition of NanoSynex
Horn & Co. represented Nanosynex Ltd. in the deal. Qualigen Therapeutics, Inc. has completed the acquisition of a majority stake in NanoSynex Ltd., an Israeli-based developer...
Prisma Photonics’ $20 Million Capital Raising
Horn & Co. advised Prisma Photonics on the deal. ERM advised Future Energy Ventures on the transaction. Prisma Photonics Ltd. executed a $20 million raise from Insight...
INX Digital Company’s Reverse Takeover
Horn & Co. advised INX Digital Company on the deal. INX Digital Company, Inc. closed its reverse takeover transaction. INX Digital Company Inc. which include regulated trading platforms for digital...